A real‐world, non‐interventional, prospective study of the effectiveness and safety of apremilast in bio‐naïve adults with moderate plaque psoriasis treated in the routine care in Greece – the ‘APRAISAL’ study
Background Real‐world data in patients with moderate psoriasis treated with apremilast is limited. Objectives To evaluate the effectiveness and safety of apremilast in bio‐naïve patients with moderate psoriasis in real‐world clinical settings. Methods This was a 52‐week multicenter, observational, p...
Gespeichert in:
Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2022-11, Vol.36 (11), p.2055-2063 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Real‐world data in patients with moderate psoriasis treated with apremilast is limited.
Objectives
To evaluate the effectiveness and safety of apremilast in bio‐naïve patients with moderate psoriasis in real‐world clinical settings.
Methods
This was a 52‐week multicenter, observational, prospective study of adult outpatients with moderate psoriasis {[10% |
---|---|
ISSN: | 0926-9959 1468-3083 |
DOI: | 10.1111/jdv.18166 |